U.S. Public Health Service stated a new recommendation for doctors concerning fighting against smoking. The act declares that the patients interested in stop smoking are recommended to use a new drug Chantix. The drug is considered to be the most effective to fight against smoking despite the probable high risk of depression during Chantix use and reveals the best values during clinical trials. The analysis of 83 clinical researches has shown that Chantix helped to stop smoking to 33 percent within half a year of the patients whereas at in placebo treatment this value was only 14 percent.
To learn the drug and its action better, read the following information about it to understand if this drug is as good as it is declared.  
Varenicline (the brand name of Chantix) has been designed by pharmaceutical company Pfizer. The first sales were in 2006. Chantix is applied as a smoking-cessation remedy for adults. In 2007 Jotham Coe (chemist who invented the drug) was awarded with the Pfizer Global R & D Achievement Award, The Award for Scientific Excellence in Chemistry and the W.E. Upjohn Award for Innovation. All this proves high efficiency and effectiveness of Chantix.